Cargando…
Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
Interleukin (IL)-33 and IL-37 have been identified as novel cytokines involved in various inflammatory diseases. However, their specific roles remain largely unknown. Recent studies have shown that IL-33, which triggers inflammation, and IL-37, which suppresses it, cooperatively regulate the balance...
Autores principales: | Tsuji, Gaku, Yamamura, Kazuhiko, Kawamura, Koji, Kido-Nakahara, Makiko, Ito, Takamichi, Nakahara, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572928/ https://www.ncbi.nlm.nih.gov/pubmed/37834081 http://dx.doi.org/10.3390/ijms241914633 |
Ejemplares similares
-
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
por: Tsuji, Gaku, et al.
Publicado: (2023) -
Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
por: Furue, Masutaka, et al.
Publicado: (2019) -
Aryl Hydrocarbon Receptor Activation Downregulates IL-33 Expression in Keratinocytes via Ovo-Like 1
por: Tsuji, Gaku, et al.
Publicado: (2020) -
IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis
por: Vu, Yen Hai, et al.
Publicado: (2020) -
Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis
por: Tsuji, Gaku, et al.
Publicado: (2017)